These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3319347)

  • 21. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.
    Duchin KL; McKinstry DN; Cohen AI; Migdalof BH
    Clin Pharmacokinet; 1988 Apr; 14(4):241-59. PubMed ID: 3292102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolism and pharmacology of D-penicillamine in man.
    Perrett D
    J Rheumatol Suppl; 1981; 7():41-50. PubMed ID: 7014876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of an electrochemical detector with a graphite electrode to liquid chromatographic determination of penicillamine and captopril in biological samples.
    Wakabayashi H; Yamato S; Nakajima M; Shimada K
    J Pharm Biomed Anal; 1994 Sep; 12(9):1147-52. PubMed ID: 7803566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid chromatography/tandem mass spectrometry determination of (4S,2RS)-2,5,5-trimethylthiazolidine-4-carboxylic acid, a stable adduct formed between D-(-)-penicillamine and acetaldehyde (main biological metabolite of ethanol), in plasma, liver and brain rat tissues.
    Serrano E; Pozo OJ; Beltrán J; Hernández F; Font L; Miquel M; Aragon CM
    Rapid Commun Mass Spectrom; 2007; 21(7):1221-9. PubMed ID: 17330215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of D-penicillamine in plasma by fluorescence derivatisation with N-[p-(2-benzoxazolyl)-phenyl] maleimide and high-performance liquid chromatography.
    Miners JO; Fearnley I; Smith KJ; Birkett DJ; Brooks PM; Whitehouse MW
    J Chromatogr; 1983 Jun; 275(1):89-96. PubMed ID: 6874874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioavailability and pharmacokinetics of D-penicillamine.
    Kukovetz WR; Beubler E; Kreuzig F; Moritz AJ; Nirnberger G; Werner-Breitenecker L
    J Rheumatol; 1983 Feb; 10(1):90-4. PubMed ID: 6842492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penicillamine: pharmacokinetics and differential effects on zinc and copper status in chicks.
    Lü JX; Combs GF
    J Nutr; 1992 Feb; 122(2):355-62. PubMed ID: 1732476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of ketanserin.
    Persson B; Heykants J; Hedner T
    Clin Pharmacokinet; 1991 Apr; 20(4):263-79. PubMed ID: 2036747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High performance liquid chromatography analysis of D-penicillamine by derivatization with N-(1-pyrenyl)maleimide (NPM).
    Yusof M; Neal R; Aykin N; Ercal N
    Biomed Chromatogr; 2000 Dec; 14(8):535-40. PubMed ID: 11113937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-penicillamine metabolism: the role of transformation in blood plasma.
    Joyce DA; Murphy BR
    Agents Actions; 1990 Nov; 31(3-4):353-7. PubMed ID: 2085148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of urinary cystine and cysteinyl-penicillamine in patients with cystinuria.
    Sampson DC; Stewart PM; Hammond JW
    Biomed Chromatogr; 1986 Feb; 1(1):21-6. PubMed ID: 3506814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of D-penicillamine in serum and urine of patients with rheumatoid arthritis.
    Muijsers AO; Van de Stadt RJ; Henrichs AM; Van der Korst JK
    Clin Chim Acta; 1979 Jun; 94(2):173-80. PubMed ID: 455728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Pharmacokinetics of indomethacin.
    Helleberg L
    Clin Pharmacokinet; 1981; 6(4):245-58. PubMed ID: 7249487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in rats.
    Orrico A; Martí-Prats L; Cano-Cebrián MJ; Polache A; Zornoza T; Granero L
    Biopharm Drug Dispos; 2014 Jul; 35(5):284-95. PubMed ID: 24619946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantiomeric reversed-phase high-performance liquid chromatography resolution of D-/L-penicillamine after spirocyclization with ninhydrin and by using copper(II)-L-proline complex as a chiral selector in the mobile phase.
    Sotgia S; Zinellu A; Pisanu E; Pinna GA; Deiana L; Carru C
    J Chromatogr A; 2008 Sep; 1205(1-2):90-3. PubMed ID: 18723178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.